Introduction/Background Recent cervical cancer screening guidelines recommend complementary Pap smear test and colposcopy examination in patients with a positive high-risk human papillomavirus (HPV) test. This study aimed to evaluate the role of HPV genotype in colposcopy examination needed in cervical intra-epithelial neoplasia (CIN) screening.
Results In this study, 621 women were evaluated with a positive high-risk HPV (HPV-16 =184, HPV-18 =69, and HPV-others=368). From 184 positive HPV-16, 37 cases had CIN3+ (20%), which this rate was 8% in NILM, 20% in ASCUS, 15% in LSIL. Out of 69 positive HPV-18, 11 cases had CIN3+ (15.9%), which this rate was 4.7% in NILM, 10% in ASCUS, 16.6% in LSIL. Out of 368 HPV-others positive, only 7 cases had CIN3+ (1.9%), which this rate was 3.2% in NILM, with no case of CIN3+ in ASCUS, and LSIL.
Conclusion According to our findings, it seems colposcopy examination in patients with positive others high-risk HPV should be considered only in high-grade (ASCH, HSIL, and ACG) Pap smear results.
Disclosures The authors indicate no conflict of interest.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.